TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34175001

Group type: EXPERIMENTAL
Intervention: Targeted self-help intervention (eTARGET group)
Number of subjects: 2896

Group type: EXPERIMENTAL
Intervention: Generic smoking cessation self-help booklets (GENERIC group)
Number of subjects: 2896

Group type: COMPARATOR
Intervention: Assessment only (ASSESS group)
Number of subjects: 2896
Study: 32295645

Group type: EXPERIMENTAL
Intervention: Motion-control shoes
Number of subjects: 92

Group type: COMPARATOR
Intervention: Neutral shoes
Number of subjects: 92
Study: 36110573

Group type: EXPERIMENTAL
Intervention: Comprehensive nursing (OG)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Conventional nursing (CG)
Number of subjects: 180
Study: 33075806

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg) added to verinurad (9 mg) and febuxostat (80 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo added to verinurad (9 mg) and febuxostat (80 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg)
Number of subjects: 36
Study: 32063089

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplement (LNS) provided to women during gestation and the first 6 months postpartum and to their infants from age 6 to 18 months.
Number of subjects: 364

Group type: COMPARATOR
Intervention: Iron and folic acid (IFA) during gestation with no infant supplementation.
Number of subjects: 364

Group type: COMPARATOR
Intervention: Multiple micronutrients during gestation and the first 6 months postpartum, with no infant supplementation.
Number of subjects: 364
Study: 33527249

Group type: EXPERIMENTAL
Intervention: Saline ultrasound (SIS)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Office hysteroscopy (HSC)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both SIS and HSC
Number of subjects: 100
Study: 35189374

Group type: EXPERIMENTAL
Intervention: Culturally-tailored infographic
Number of subjects: 1100

Group type: COMPARATOR
Intervention: Traditional standard infographic
Number of subjects: 1100

Group type: EXPERIMENTAL
Intervention: Culturally-tailored comic book
Number of subjects: 1100
Study: 35300944

Group type: EXPERIMENTAL
Intervention: SCF-N-treated needles
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stainless steel needles
Number of subjects: 0
Study: 32246762

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone (400 mg pessary) once daily until 37 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: No progesterone
Number of subjects: 0
Study: 35953433

Group type: EXPERIMENTAL
Intervention: Nasobiliary catheter insertion during ERCP (NB group)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (only CBD clearance)
Number of subjects: 110
Study: 33599345

Group type: EXPERIMENTAL
Intervention: Crocin (15 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Fluoxetine (20 mg)
Number of subjects: 50
Study: 33148013

Group type: EXPERIMENTAL
Intervention: Edoxaban 60 mg (30 mg dose-reduced)
Number of subjects: 14024

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 14024
Study: 35661856

Group type: EXPERIMENTAL
Intervention: Electronic symptom monitoring with PRO surveys (n=593)
Number of subjects: 1191

Group type: COMPARATOR
Intervention: Usual care (n=598)
Number of subjects: 1191
Study: 35781768

Group type: EXPERIMENTAL
Intervention: Population-screening (PS)
Number of subjects: 1034

Group type: COMPARATOR
Intervention: Family history (FH)
Number of subjects: 1034

Group type: EXPERIMENTAL
Intervention: Population-screening (PS) and Family history (FH)
Number of subjects: 1034

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 1034
Study: 33992536

Group type: EXPERIMENTAL
Intervention: Intravenous autologous bone marrow-derived mesenchymal stromal cells (BMMSCs) at a dosage of 2 million cells per kilogram of body weight
Number of subjects: 17

Group type: COMPARATOR
Intervention: Standard medical care (control group)
Number of subjects: 17
Study: 32290880

Group type: EXPERIMENTAL
Intervention: Fundraising Incentive (FI)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Fundraising-Healthy Eating Incentive (F-HEI)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Comparison 1
Number of subjects: 81
Study: 34433601

Group type: EXPERIMENTAL
Intervention: Multidisciplinary group programme (Energetic) consisting of a 4 months intervention with weekly meetings covering four modules: aerobic exercise training, education about aerobic exercise, self-management training, and implementation and relapse prevention.
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Qualitative data collection through individual and focus group interviews.
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Suggestions for programme improvement include a combination of face to face and e-health, enhancement of therapists' skills, and inclusion of more booster sessions.
Number of subjects: 29
Study: 34319941

Group type: EXPERIMENTAL
Intervention: Simultaneous bilateral resistance training (BIL)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Alternating unilateral resistance training (AUL)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 24
Study: 33744205

Group type: EXPERIMENTAL
Intervention: Interpositional gap arthroplasty followed by reconstruction of the ramus-condyle unit using vertical ramus osteotomy
Number of subjects: 16

Group type: COMPARATOR
Intervention: Interpositional gap arthroplasty
Number of subjects: 16
Study: 33110649

Group type: EXPERIMENTAL
Intervention: BCG vaccine
Number of subjects: 201

Group type: COMPARATOR
Intervention: Topical salicylic acid (SA)
Number of subjects: 201
Study: 36029051

Group type: EXPERIMENTAL
Intervention: 10000 IU of hCG plus 450 IU of FSH
Number of subjects: 117

Group type: COMPARATOR
Intervention: 10000 IU of hCG alone
Number of subjects: 117
Study: 33609965

Group type: EXPERIMENTAL
Intervention: Letters of invitation for cervical cancer screening
Number of subjects: 0

Group type: COMPARATOR
Intervention: Different ways of framing messages
Number of subjects: 0
Study: 36347387

Group type: EXPERIMENTAL
Intervention: MSC therapy (infused at weeks 6 and 7 after transplantation, tacrolimus withdrawn at week 8)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: MSC therapy
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard tacrolimus dose (control group)
Number of subjects: 54
Study: 34433000

Group type: EXPERIMENTAL
Intervention: High-Intensity Speech Intervention (HISI)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low-Intensity Speech Intervention (LISI)
Number of subjects: 12
Study: 32187609

Group type: EXPERIMENTAL
Intervention: Fingolimod (FIN)
Number of subjects: 388

Group type: COMPARATOR
Intervention: Natalizumab (NTZ)
Number of subjects: 388
Study: 36175473

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 33161000

Group type: EXPERIMENTAL
Intervention: Endodontic microsurgery (EMS) treated teeth
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control teeth
Number of subjects: 14
Study: 35289144

Group type: EXPERIMENTAL
Intervention: 2-mSv CT
Number of subjects: 3074

Group type: COMPARATOR
Intervention: Conventional-dose CT
Number of subjects: 3074
Study: 34962110

Group type: EXPERIMENTAL
Intervention: PCV-VG
Number of subjects: 80

Group type: COMPARATOR
Intervention: VCV
Number of subjects: 80
Study: 34582545

Group type: EXPERIMENTAL
Intervention: Low-Carb diet (20% carbohydrate, 21% saturated fat)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Moderate-Carb diet (40% carbohydrate, 14% saturated fat)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: High-Carb diet (60% carbohydrate, 7% saturated fat)
Number of subjects: 164
Study: 32354945

Group type: EXPERIMENTAL
Intervention: Bevacizumab monotherapy
Number of subjects: 32
Study: 34587873

Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise program (8 weeks, home-based)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Routine activities (control group)
Number of subjects: 34
Study: 32820132

Group type: EXPERIMENTAL
Intervention: Combined strength and power training (twice a week for 8 weeks)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Soccer training alone (control group)
Number of subjects: 37
Study: 35831410

Group type: EXPERIMENTAL
Intervention: Gold weight fixed 2 mm above the eyelash line (GLE group)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Gold weight fixed at the border of the tarsus and the levator aponeurosis (GUE group)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Platinum chain fixed at the border of the tarsus and the levator aponeurosis (PUE group)
Number of subjects: 94
Study: 32657253

Group type: EXPERIMENTAL
Intervention: Diesel exhaust (DE) exposure
Number of subjects: 16
Study: 32207134

Group type: EXPERIMENTAL
Intervention: General anesthesia (GA)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Spinal anesthesia (SA)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Epidural anesthesia (EA)
Number of subjects: 105
Study: 35396456

Group type: EXPERIMENTAL
Intervention: Arm-cycle ergometry (ACET)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Body weight supported treadmill training (BWSTT)
Number of subjects: 35
Study: 33275811

Group type: EXPERIMENTAL
Intervention: Dissonance-based (DB) intervention
Number of subjects: 180

Group type: COMPARATOR
Intervention: Assessment-only control (AOC)
Number of subjects: 180
Study: 33099850

Group type: EXPERIMENTAL
Intervention: Coolsense plus standard care
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Buzzy with cold plus standard care
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Buzzy without cold plus standard care
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard care alone (distraction with bubbles)
Number of subjects: 40
Study: 33082214

Group type: EXPERIMENTAL
Intervention: FGFR1 copy-number gains (CNGs)
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: PIK3CA mutations
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: MYC CNGs
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: CCND1 CNGs
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: ERBB2 CNGs
Number of subjects: 598
Study: 32078716

Group type: EXPERIMENTAL
Intervention: Training cohort (n=6941)
Number of subjects: 9917

Group type: EXPERIMENTAL
Intervention: Fine and Gray's model
Number of subjects: 9917

Group type: EXPERIMENTAL
Intervention: Competing risk nomogram
Number of subjects: 9917
Study: 32324130

Group type: COMPARATOR
Intervention: NAPSO 220 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: NAPSO 440 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: NAPSO 550 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: NAP 500 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher doses of NAPSO
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower doses of NAPSO (220 mg, 440 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher strengths of NAPSO
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active treatments
Number of subjects: 0
Study: 34358343

Group type: EXPERIMENTAL
Intervention: Dupilumab (300 mg) every 2 weeks for 16 weeks
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Dupilumab (300 mg)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study: 33640591

Group type: EXPERIMENTAL
Intervention: Self-criticism induction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-compassion induction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral control condition
Number of subjects: 0
Study: 36272353

Group type: EXPERIMENTAL
Intervention: Tiotropium 18µg
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Glycopyrronium 44µg
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Indacaterol 150µg
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 34
Study: 32818546

Group type: EXPERIMENTAL
Intervention: Positive media information
Number of subjects: 2176

Group type: EXPERIMENTAL
Intervention: Negative media information
Number of subjects: 2176

Group type: COMPARATOR
Intervention: Reference group (no media information)
Number of subjects: 2176
Study: 35449062

Group type: EXPERIMENTAL
Intervention: tDCS anodal stimulation
Number of subjects: 23

Group type: COMPARATOR
Intervention: tDCS cathodal stimulation
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 23
Study: 33144646

Group type: EXPERIMENTAL
Intervention: Anodic stimulation for five consecutive days
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Anodic stimulation for ten consecutive days
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sham stimulation for five consecutive days
Number of subjects: 31
Study: 35684150

Group type: EXPERIMENTAL
Intervention: Responsive parenting intervention
Number of subjects: 185

Group type: COMPARATOR
Intervention: Child safety control intervention
Number of subjects: 185
Study: 34161616

Group type: EXPERIMENTAL
Intervention: Eliglustat
Number of subjects: 40
Study: 34011736

Group type: EXPERIMENTAL
Intervention: Corneal crosslinking (CXL)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control subjects (no CXL)
Number of subjects: 18
Study: 32078391

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 2 mg/kg or 10 mg/kg every 3 weeks (up to 35 cycles/2 years)
Number of subjects: 1033

Group type: COMPARATOR
Intervention: Docetaxel 75 mg/m2 every 3 weeks
Number of subjects: 1033

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (second-course treatment)
Number of subjects: 1033

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (after completing treatment)
Number of subjects: 1033
Study: 35419725

Group type: EXPERIMENTAL
Intervention: Acupuncture intervention at two acupoint groups for 30 min once every other day during ovulation induction until transplantation day, consisting of 3 courses.
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control group (no acupuncture intervention).
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Acupuncture intervention.
Number of subjects: 83
Study: 33846971

Group type: EXPERIMENTAL
Intervention: 400 mg CBD
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 32221185

Group type: EXPERIMENTAL
Intervention: Computer use
Number of subjects: 199
Study: 33945842

Group type: EXPERIMENTAL
Intervention: Physical activity and diet intervention; physical activity, diet, and sleep intervention
Number of subjects: 116
Study: 32076105

Group type: EXPERIMENTAL
Intervention: Active tDCS intervention
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham tDCS intervention
Number of subjects: 38
Study: 35887581

Group type: EXPERIMENTAL
Intervention: Patient-specific spinal drill guides (3DPGs)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Computer-assisted surgery (CAS)
Number of subjects: 10
Study: 32629639

Group type: EXPERIMENTAL
Intervention: Trimodal home-based prehabilitation (nutritional, psychological, and exercise interventions)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (no prehabilitation)
Number of subjects: 128
Study: 35384847

Group type: EXPERIMENTAL
Intervention: OnTrack>The Game (OTG)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Recovery Videos (RVs)
Number of subjects: 16
Study: 36179725

Group type: EXPERIMENTAL
Intervention: High depressive symptoms group (14 participants)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Low depressive symptoms group (10 participants)
Number of subjects: 24
Study: 32935561

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) - Dexcom G6
Number of subjects: 99

Group type: COMPARATOR
Intervention: Finger Stick Glucometer (FSG) - Contour Next One
Number of subjects: 99
Study: 35583161

Group type: EXPERIMENTAL
Intervention: Prowel® (synbiotic drug)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 34751654

Group type: EXPERIMENTAL
Intervention: WeChat-based intervention comprising cognitive-behavioral stress management (CBSM) courses and physical activity promotion for 3 months
Number of subjects: 300

Group type: COMPARATOR
Intervention: Printed brochure on nutrition guidelines in addition to usual care for HIV treatment
Number of subjects: 300
Study: 32072434

Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Physical activity (PA) intervention
Number of subjects: 223

Group type: COMPARATOR
Intervention: Combined intervention
Number of subjects: 223

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 223
Study: 35419911

Group type: EXPERIMENTAL
Intervention: SF-01
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ellansé-M®
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SF-01 and Ellansé-M®
Number of subjects: 0
Study: 34418719

Group type: EXPERIMENTAL
Intervention: Compression (2 kg pressure applied after FNB)
Number of subjects: 34

Group type: COMPARATOR
Intervention: No Compression (no pressure applied after FNB)
Number of subjects: 34
Study: 32859145

Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (3 mg/kg dextrose)
Number of subjects: 24
Study: 32459016

Group type: EXPERIMENTAL
Intervention: Topical 6% gabapentin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (plain permeation cream)
Number of subjects: 30
Study: 35179756

Group type: EXPERIMENTAL
Intervention: Somatic Acupuncture (SA)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Auricular Acupuncture (AA)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Pharmacological Treatment (PT)
Number of subjects: 120
Study: 35691487

Group type: EXPERIMENTAL
Intervention: Active support from trusted community health workers
Number of subjects: 400

Group type: COMPARATOR
Intervention: Passive support (no active support)
Number of subjects: 400
Study: 32011825

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 35314634

Group type: EXPERIMENTAL
Intervention: Belinostat (500-750 mg/m2 1×/day × 5 days every three weeks)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (standard-of-care therapy including temozolomide and radiation therapy)
Number of subjects: 26
Study: 34596671

Group type: EXPERIMENTAL
Intervention: Immediate IBBR with Acellular Dermal Matrix (ADM)
Number of subjects: 135

Group type: COMPARATOR
Intervention: IBBR without Acellular Dermal Matrix (Control)
Number of subjects: 135
Study: 32503004

Group type: EXPERIMENTAL
Intervention: 12-week aerobic and resistance exercise training (n = 23)
Number of subjects: 45

Group type: COMPARATOR
Intervention: No exercise group (control, n = 22)
Number of subjects: 45
Study: 35834228

Group type: EXPERIMENTAL
Intervention: Mismatch Repair Deficiency (MMRD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mismatch Repair Proficiency (MMRP)
Number of subjects: 0
Study: 35351367

Group type: EXPERIMENTAL
Intervention: Self-acupressure (16 sessions, 2 days a week, 27 min each session)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Self-acupressure
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 62
Study: 32032233

Group type: EXPERIMENTAL
Intervention: VMAX (squat with intention to move the bar as fast as possible)
Number of subjects: 14

Group type: COMPARATOR
Intervention: CON (controlled half-squat at self-selected normal tempo)
Number of subjects: 14
Study: 33108690

Group type: EXPERIMENTAL
Intervention: Fairplayer.Sport intervention
Number of subjects: 145

Group type: COMPARATOR
Intervention: Waiting-control group
Number of subjects: 145
Study: 33267729

Group type: COMPARATOR
Intervention: NORMAL group (unprocessed speech signal in contralateral ear)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: LOWPASS group (low-pass filtered speech signal in contralateral ear)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: NOTHING group (no sound in contralateral ear)
Number of subjects: 60
Study: 32474427

Group type: EXPERIMENTAL
Intervention: LARS patient‐centred programme (LPCP) consisting of an informational booklet, patient diaries, and nurse support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 34144246

Group type: EXPERIMENTAL
Intervention: MOVE! + UP
Number of subjects: 164

Group type: COMPARATOR
Intervention: MOVE!
Number of subjects: 164
Study: 32620717

Group type: COMPARATOR
Intervention: Mouthwash containing 0.12% chlorhexidine‐gluconate (Group 2)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: No mouthwash (Group 1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Mouthwash containing essential-oils (Group 3)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Mouthwash containing 7.5% povidone-iodine (Group 4)
Number of subjects: 40
Study: 36002106

Group type: EXPERIMENTAL
Intervention: Single-unit UCB transplantation
Number of subjects: 278

Group type: COMPARATOR
Intervention: Real-world group (RW) with single-unit UCB transplantation
Number of subjects: 278

Group type: COMPARATOR
Intervention: Real-world group (RW)
Number of subjects: 278
Study: 34571090

Group type: EXPERIMENTAL
Intervention: WBRT + boost (arm B)
Number of subjects: 2004

Group type: COMPARATOR
Intervention: WBRT (arm A)
Number of subjects: 2004
Study: 32927741

Group type: EXPERIMENTAL
Intervention: Nutritional education and a low to moderate multi-component exercise program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control arm (not specified)
Number of subjects: 60
Study: 36183129

Group type: EXPERIMENTAL
Intervention: Your Care Needs You (YCNY) intervention
Number of subjects: 161

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 161
Study: 34715827

Group type: EXPERIMENTAL
Intervention: Antifungal therapy after surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no antifungal therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antifungal therapy
Number of subjects: 0
Study: 35164485

Group type: EXPERIMENTAL
Intervention: Opioid-free anesthesia (OFA)
Number of subjects: 78
Study: 34004271

Group type: EXPERIMENTAL
Intervention: Phytobiotic blend (FTB)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Synthetic antibiotic (ATB)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 56
Study: 32447657

Group type: EXPERIMENTAL
Intervention: Anti-PD-1/PD-L1 monoclonal antibodies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination immunotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-PD-1/PD-L1
Number of subjects: 0
Study: 36372870

Group type: EXPERIMENTAL
Intervention: Game-based real-time feedback intervention
Number of subjects: 13
Study: 32693660

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) along with pharmacotherapy (PT)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Pharmacotherapy (PT) only
Number of subjects: 150